Bonus BioGroup Statistics

Total Valuation

Bonus BioGroup has a market cap or net worth of ILS 109.78 million. The enterprise value is 111.61 million.

Market Cap	109.78M
Enterprise Value	111.61M

Important Dates

The last earnings date was Thursday, November 28, 2024.

Earnings Date	Nov 28, 2024
Ex-Dividend Date	n/a

Share Statistics

Bonus BioGroup has 1.17 billion shares outstanding.

Current Share Class	n/a
Shares Outstanding	1.17B
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	57.27%
Owned by Institutions (%)	0.03%
Float	499.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	12.52
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.79
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.77

Financial Position

The company has a current ratio of 1.09, with a Debt / Equity ratio of 1.20.

Current Ratio	1.09
Quick Ratio	1.09
Debt / Equity	1.20
Debt / EBITDA	n/a
Debt / FCF	-0.45
Interest Coverage	-37.06

Financial Efficiency

Return on equity (ROE) is -129.44% and return on invested capital (ROIC) is -53.70%.

Return on Equity (ROE)	-129.44%
Return on Assets (ROA)	-46.14%
Return on Capital (ROIC)	-53.70%
Revenue Per Employee	n/a
Profits Per Employee	-508,086
Employee Count	58
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -44.05% in the last 52 weeks. The beta is 1.02, so Bonus BioGroup's price volatility has been similar to the market average.

Beta (5Y)	1.02
52-Week Price Change	-44.05%
50-Day Moving Average	11.24
200-Day Moving Average	15.20
Relative Strength Index (RSI)	25.03
Average Volume (20 Days)	2,295,153

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-29.02M
Pretax Income	-29.47M
Net Income	-29.47M
EBITDA	-27.33M
EBIT	-29.02M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 8.73 million in cash and 10.56 million in debt, giving a net cash position of -1.82 million or -0.00 per share.

Cash & Cash Equivalents	8.73M
Total Debt	10.56M
Net Cash	-1.82M
Net Cash Per Share	-0.00
Equity (Book Value)	8.78M
Book Value Per Share	n/a
Working Capital	771,000

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -22.99 million and capital expenditures -420,000, giving a free cash flow of -23.41 million.

Operating Cash Flow	-22.99M
Capital Expenditures	-420,000
Free Cash Flow	-23.41M
FCF Per Share	-0.02

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Bonus BioGroup does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a